Filing Flows › Neogen (NEOG) › Q1 FY27 › vs Q1 FY26
Neogen (NEOG) Q1 FY27 vs Q1 FY26 (year over year)
Neogen's revenue rose $13.6M (+7%) from $209M in Q1 FY26 to $223M in Q1 FY27. The biggest changes: Product +$11.9M (+6%); Service +$1.7M (+7%).
Neogen, Q1 FY27: revenue $223M (+6% year over year), operating margin -0.8%, net loss $11.9M, operating cash flow $12.9M. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Product | $196M | $184M | $11.9M | +6% |
| Service | $26.8M | $25.1M | $1.7M | +7% |
| Revenue | $223M | $209M | $13.6M | +7% |
| Income tax benefit | $3.0M | −$7.5M | $10.5M | — |
| Net loss | $11.9M | −$36.3M | $48.2M | — |
| Costs & expenses | $238M | $269M | −$31.4M | -12% |
| Operating costs | $225M | $225M | −$700K | -0.3% |
| Interest & other, net | $13.1M | −$59.9M | $73.0M | — |
| Cost of revenue | $117M | $114M | $3.1M | +3% |
| Research & development | $6.5M | $5.1M | $1.4M | +27% |
| Sales & marketing | $41.5M | $45.1M | −$3.6M | -8% |
| General & admin | $59.3M | $60.9M | −$1.6M | -3% |
| Operating cash sources | $32.2M | $34.1M | −$1.9M | -6% |
| Depreciation & amortization | $29.1M | $29.1M | $0 | 0% |
| Share-based compensation | $3.1M | $5.0M | −$1.9M | -38% |
| Net loss absorbed | $11.9M | −$36.3M | $48.2M | — |
| Working capital & other | $7.4M | $59.6M | −$52.2M | -88% |
| Operating cash flow | $12.9M | $10.8M | $2.1M | +19% |
Questions
How much did Neogen's revenue grow year over year in Q1 FY27?
Neogen's revenue rose $13.6M (+7%) from $209M in Q1 FY26 to $223M in Q1 FY27.
What drove Neogen's revenue change in Q1 FY27?
Product +$11.9M (+6%); Service +$1.7M (+7%).